Results suggest that high concentration of phosphatidylcholine nanoparticles at pH 7.0 induces activation of the MEK1/2-ERK1/2 pathway and cell proliferation of the breast cancer cells. This evidence concerns the gene MAPK3 and breast carcinoma.